Company Filing History:
Years Active: 2001-2010
Title: Holger Sann: Innovating Pain Management in Hannover
Introduction
Holger Sann, an inventive mind based in Hannover, Germany, has made significant contributions to the field of pharmaceuticals. With a notable portfolio of 10 patents, Sann's work focuses primarily on innovative methods for treating abdominal disorders associated with pain.
Latest Patents
Among his latest creations, Sann has developed a method for treating non-digestive tract derived abdominal disorders using a 5-HT receptor antagonist. This particular method targets conditions such as interstitial cystitis, chronic pelvic pain syndrome, and abdominal pain linked to endometriosis. By administering a pharmaceutically effective amount of cilansetron or its derivatives, patients can find relief from their debilitating symptoms.
Additionally, he has patented 4-substituted 1-amidomethylcarbonyl-piperidine compounds that exhibit motilin-agonistic properties. This innovation includes the development of pharmaceutical formulations and production methods for these compounds, providing new avenues for treatment options.
Career Highlights
Holger Sann is currently affiliated with Solvay Pharmaceuticals GmbH, a company well-regarded for its dedication to advancing healthcare solutions. His work demonstrates a commitment to improving patient care through scientific research and innovative medical advancements.
Collaborations
Throughout his career, Sann has collaborated with esteemed colleagues, including Jochen Antel and Ulf Preuschoff. These partnerships highlight the importance of teamwork in driving innovation and addressing complex medical challenges.
Conclusion
Holger Sann's contributions to the pharmaceutical industry, particularly in pain management, underscore his role as a vital inventor. His latest patents reflect a proactive approach to developing solutions that enhance the quality of life for patients suffering from significant abdominal disorders. With continued research and collaboration, Sann is poised to make even more impactful advancements in the field.